Circular RNA startup Orbital unveils first monkey data as it enters in vivo CAR-T cell therapy racenews2025-07-22T10:00:54+00:00July 22nd, 2025|Endpoints News|
Endpoints livestream: What happens next with Sarepta’s Duchenne crisis? news2025-07-21T15:14:09+00:00July 21st, 2025|Endpoints News|
Sail Bio cuts staff by 30% and trims leadership teamnews2025-07-18T19:43:18+00:00July 18th, 2025|Endpoints News|
Peter Marks says Sarepta gene therapy pause ‘makes sense’news2025-07-18T19:05:54+00:00July 18th, 2025|Endpoints News|
Sarepta lays off 500 people, adds black box warning to DMD therapynews2025-07-16T21:02:25+00:00July 16th, 2025|Endpoints News|
FDA rejects Ultragenyx’s Sanfilippo gene therapy over manufacturing issuesnews2025-07-14T11:38:31+00:00July 14th, 2025|Endpoints News|
AstraZeneca’s Alexion inks AAV capsid deal with JCR Pharmanews2025-07-09T11:07:05+00:00July 9th, 2025|Endpoints News|
‘CRISPR Cures’ center launches to make custom gene editing therapiesnews2025-07-08T19:59:53+00:00July 8th, 2025|Endpoints News|
Shell company Concentra has found its rhythm, with Cargo Therapeutics as its latest buyout targetnews2025-07-08T11:25:01+00:00July 8th, 2025|Endpoints News|
SCG Cell Therapy gets China thumbs-up for study of potentially curative HBV treatmentnews2025-07-08T11:17:10+00:00July 8th, 2025|Endpoints News|
